MedPath

NP Thyroid 30

NP Thyroid 30

Approved
Approval ID

2eabc9b4-2d5c-44b2-bf05-eb6c3260c1bd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 28, 2023

Manufacturers
FDA

Acella Pharmaceuticals, LLC

DUNS: 825380939

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LEVOTHYROXINE, LIOTHYRONINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42192-329
Product Classification
G
Generic Name
LEVOTHYROXINE, LIOTHYRONINE
Product Specifications
Route of AdministrationORAL
Effective DateApril 28, 2023
FDA Product Classification

INGREDIENTS (5)

MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
LIOTHYRONINEActive
Quantity: 4.5 ug in 1 1
Code: 06LU7C9H1V
Classification: ACTIB
LEVOTHYROXINEActive
Quantity: 19 ug in 1 1
Code: Q51BO43MG4
Classification: ACTIB
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
DEXTROSE MONOHYDRATEInactive
Code: LX22YL083G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NP Thyroid 30 - FDA Drug Approval Details